Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

NCT02553187 is registered in ClinicalTrials.gov with Zhejiang Kanglaite Pharmaceutical Co.Ltd as lead sponsor.

NCT NCT02553187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02553187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia
Lead sponsor
Zhejiang Kanglaite Pharmaceutical Co.Ltd
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2015
Completion date
July 31, 2018
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer cachexia